Literature DB >> 20332240

Malignant germ cell tumors display common microRNA profiles resulting in global changes in expression of messenger RNA targets.

Roger D Palmer1, Matthew J Murray, Harpreet K Saini, Stijn van Dongen, Cei Abreu-Goodger, Balaji Muralidhar, Mark R Pett, Claire M Thornton, James C Nicholson, Anton J Enright, Nicholas Coleman.   

Abstract

Despite their extensive clinical and pathologic heterogeneity, all malignant germ cell tumors (GCT) are thought to originate from primordial germ cells. However, no common biological abnormalities have been identified to date. We profiled 615 microRNAs (miRNA) in pediatric malignant GCTs, controls, and GCT cell lines (48 samples in total) and re-analyzed available miRNA expression data in adult gonadal malignant GCTs. We applied the bioinformatic algorithm Sylamer to identify miRNAs that are of biological importance by inducing global shifts in mRNA levels. The most significant differentially expressed miRNAs in malignant GCTs were all from the miR-371-373 and miR-302 clusters (adjusted P < 0.00005), which were overexpressed regardless of histologic subtype [yolk sac tumor (YST)/seminoma/embryonal carcinoma (EC)], site (gonadal/extragonadal), or patient age (pediatric/adult). Sylamer revealed that the hexamer GCACTT, complementary to the 2- to 7-nucleotide miRNA seed AAGUGC shared by six members of the miR-371-373 and miR-302 clusters, was the only sequence significantly enriched in the 3'-untranslated region of mRNAs downregulated in pediatric malignant GCTs (as a group), YSTs and ECs, and in adult YSTs (all versus nonmalignant tissue controls; P < 0.05). For the pediatric samples, downregulated genes containing the 3'-untranslated region GCACTT showed significant overrepresentation of Gene Ontology terms related to cancer-associated processes, whereas for downregulated genes lacking GCACTT, Gene Ontology terms generally represented metabolic processes only, with few genes per term (adjusted P < 0.05). We conclude that the miR-371-373 and miR-302 clusters are universally overexpressed in malignant GCTs and coordinately downregulate mRNAs involved in biologically significant pathways.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20332240      PMCID: PMC3000593          DOI: 10.1158/0008-5472.CAN-09-3301

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  43 in total

1.  Normalization of cDNA microarray data.

Authors:  Gordon K Smyth; Terry Speed
Journal:  Methods       Date:  2003-12       Impact factor: 3.608

2.  Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets.

Authors:  Benjamin P Lewis; Christopher B Burge; David P Bartel
Journal:  Cell       Date:  2005-01-14       Impact factor: 41.582

Review 3.  A small piece in the cancer puzzle: microRNAs as tumor suppressors and oncogenes.

Authors:  O A Kent; J T Mendell
Journal:  Oncogene       Date:  2006-10-09       Impact factor: 9.867

4.  A genetic screen implicates miRNA-372 and miRNA-373 as oncogenes in testicular germ cell tumors.

Authors:  P Mathijs Voorhoeve; Carlos le Sage; Mariette Schrier; Ad J M Gillis; Hans Stoop; Remco Nagel; Ying-Poi Liu; Josyanne van Duijse; Jarno Drost; Alexander Griekspoor; Eitan Zlotorynski; Norikazu Yabuta; Gabriella De Vita; Hiroshi Nojima; Leendert H J Looijenga; Reuven Agami
Journal:  Cell       Date:  2006-03-24       Impact factor: 41.582

5.  Microarray analysis shows that some microRNAs downregulate large numbers of target mRNAs.

Authors:  Lee P Lim; Nelson C Lau; Philip Garrett-Engele; Andrew Grimson; Janell M Schelter; John Castle; David P Bartel; Peter S Linsley; Jason M Johnson
Journal:  Nature       Date:  2005-01-30       Impact factor: 49.962

6.  MicroRNA expression profiles classify human cancers.

Authors:  Jun Lu; Gad Getz; Eric A Miska; Ezequiel Alvarez-Saavedra; Justin Lamb; David Peck; Alejandro Sweet-Cordero; Benjamin L Ebert; Raymond H Mak; Adolfo A Ferrando; James R Downing; Tyler Jacks; H Robert Horvitz; Todd R Golub
Journal:  Nature       Date:  2005-06-09       Impact factor: 49.962

7.  Differential expression of SOX17 and SOX2 in germ cells and stem cells has biological and clinical implications.

Authors:  J de Jong; H Stoop; A J M Gillis; R J H L M van Gurp; G-J M van de Geijn; M de Boer; R Hersmus; P T K Saunders; R A Anderson; J W Oosterhuis; L H J Looijenga
Journal:  J Pathol       Date:  2008-05       Impact factor: 7.996

8.  Novel genomic amplification targeting the microRNA cluster at 19q13.42 in a pediatric embryonal tumor with abundant neuropil and true rosettes.

Authors:  Stefan Pfister; Marc Remke; Mirco Castoldi; Alfa H C Bai; Martina U Muckenthaler; Andreas Kulozik; Andreas von Deimling; Armin Pscherer; Peter Lichter; Andrey Korshunov
Journal:  Acta Neuropathol       Date:  2008-12-05       Impact factor: 17.088

9.  Prediction of mammalian microRNA targets.

Authors:  Benjamin P Lewis; I-hung Shih; Matthew W Jones-Rhoades; David P Bartel; Christopher B Burge
Journal:  Cell       Date:  2003-12-26       Impact factor: 41.582

Review 10.  OncomiRs: the discovery and progress of microRNAs in cancers.

Authors:  William C S Cho
Journal:  Mol Cancer       Date:  2007-09-25       Impact factor: 27.401

View more
  91 in total

1.  Characterization of CLL exosomes reveals a distinct microRNA signature and enhanced secretion by activation of BCR signaling.

Authors:  Yuh-Ying Yeh; Hatice Gulcin Ozer; Amy M Lehman; Kami Maddocks; Lianbo Yu; Amy J Johnson; John C Byrd
Journal:  Blood       Date:  2015-04-01       Impact factor: 22.113

Review 2.  [Testicular tumors in prepubertal boys-organ preservation possible more often than expected].

Authors:  R Stein; M Dürken; K Zahn; Nina Younsi
Journal:  Urologe A       Date:  2020-03       Impact factor: 0.639

3.  Differential expression of miRNAs in the seminal plasma and serum of testicular cancer patients.

Authors:  Marianna Pelloni; Giulia Coltrinari; Donatella Paoli; Francesco Pallotti; Francesco Lombardo; Andrea Lenzi; Loredana Gandini
Journal:  Endocrine       Date:  2016-10-28       Impact factor: 3.633

4.  Development of a Data Model and Data Commons for Germ Cell Tumors.

Authors:  Bo Ci; Donghan M Yang; Mark Krailo; Caihong Xia; Bo Yao; Danni Luo; Qinbo Zhou; Guanghua Xiao; Lin Xu; Stephen X Skapek; Matthew M Murray; James F Amatruda; Lindsay Klosterkemper; Furqan Shaikh; Cecile Faure-Conter; Brice Fresneau; Samuel L Volchenboum; Sara Stoneham; Luiz Fernando Lopes; James Nicholson; A Lindsay Frazier; Yang Xie
Journal:  JCO Clin Cancer Inform       Date:  2020-06

5.  Germ cell tumour subtypes display differential expression of microRNA371a-3p.

Authors:  Bárbara Vilela-Salgueiro; Daniela Barros-Silva; João Lobo; Ana Laura Costa; Rita Guimarães; Mariana Cantante; Paula Lopes; Isaac Braga; Jorge Oliveira; Rui Henrique; Carmen Jerónimo
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2018-06-05       Impact factor: 6.237

Review 6.  Testicular cancer: biology and biomarkers.

Authors:  Leendert H J Looijenga; Hans Stoop; Katharina Biermann
Journal:  Virchows Arch       Date:  2014-02-01       Impact factor: 4.064

7.  Bone morphogenetic protein signalling activity distinguishes histological subsets of paediatric germ cell tumours.

Authors:  N Fustino; D Rakheja; C S Ateek; J C Neumann; J F Amatruda
Journal:  Int J Androl       Date:  2011-06-22

8.  MicroRNA expression profiles of seminoma from paraffin-embedded formalin-fixed tissue.

Authors:  Z Bing; S R Master; J W Tobias; D A Baldwin; X W Xu; J E Tomaszewski
Journal:  Virchows Arch       Date:  2012-10-14       Impact factor: 4.064

9.  Inhibition of microRNA-302 (miR-302) by bone morphogenetic protein 4 (BMP4) facilitates the BMP signaling pathway.

Authors:  Hara Kang; Justin Louie; Alexandra Weisman; Jessica Sheu-Gruttadauria; Brandi N Davis-Dusenbery; Giorgio Lagna; Akiko Hata
Journal:  J Biol Chem       Date:  2012-09-17       Impact factor: 5.157

Review 10.  What radiologists should know about microRNA (miRNA) serum biomarkers for germ cell tumors.

Authors:  Matthew A Morgan; Joanie M Garratt; David J Vaughn
Journal:  Abdom Radiol (NY)       Date:  2020-08-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.